Bausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Total debt
Bausch + Lomb Corporation's total debt at the end of fiscal 2025 was $5.1B, up 6.23% from $4.8B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $5.1B. Bausch + Lomb Corporation ranks 4th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $5.1B | 6.23% |
| FY2024 | $4.8B | 4.87% |
| FY2023 | $4.6B | 87.27% |
| FY2022 | $2.4B | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $5.1B | (0.39%) |
| Jun 2026 | $5.1B | 0.89% |
| Mar 2026 | $5.1B | (0.24%) |
| Dec 2025 | $5.1B | 2.67% |
| 15 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| BLCO Bausch + Lomb Corporation | $5.1B |
| AVTR Avantor, Inc. compare | $3.7B |
| TFX Teleflex Incorporated compare | $2.8B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| ATR AptarGroup, Inc. compare | $1.4B |
| MMSI Merit Medical Systems, Inc. compare | $737.4M |
| RGEN Repligen Corporation compare | $555.6M |
| ALGN Align Technology, Inc. compare | $127.0M |
| MMED MiniMed Group, Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement